Cyclacel Pharmaceuticals Inc (CYCC)

Jan 18, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated at StockNews.com - Defense World

Jan 18, 2025

Jan 17, 2025

All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy - MSN

Jan 17, 2025

Jan 13, 2025

Cyclacel Pharmaceuticals Corrects Inadvertent Error in Securities Purchase Agreement - Defense World

Jan 13, 2025

Jan 10, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by Analysts at StockNews.com - Defense World

Jan 10, 2025

Jan 07, 2025

Cyclacel Pharmaceuticals Announces Agreement for $3.1 Million Investment by David Lazar as Interim CEO - Defense World

Jan 07, 2025

Jan 06, 2025

Cyclacel Pharmaceuticals Restructures Leadership and Financial Strategy - TipRanks

Jan 06, 2025

Jan 03, 2025

Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar - citybiz

Jan 03, 2025

Jan 03, 2025

Stock market news: Nauticus Robotics gained 93.71% while N2OFF rose by 128.03% during mid day trading - Business Upturn

Jan 03, 2025

Jan 03, 2025

Cyclacel Pharmaceuticals, Inc. Announces Chief Executive Officer Changes - Marketscreener.com

Jan 03, 2025

Jan 03, 2025

Why Cyclacel Pharmaceuticals (CYCC) Stock Is Skyrocketing - Benzinga

Jan 03, 2025

Jan 03, 2025

Cyclacel Pharmaceuticals, Inc. Announces Board Changes - Marketscreener.com

Jan 03, 2025

Jan 03, 2025

Dow Jumps Over 100 Points; ISM Manufacturing PMI Increases In December - Benzinga

Jan 03, 2025

Jan 03, 2025

David Lazar acquires Cyclacel Pharmaceuticals preferred stock, becomes interim CEO; stock jumps - Seeking Alpha

Jan 03, 2025

Jan 03, 2025

Cyclacel Pharmaceuticals Secures $3.1M Investment, Names David Lazar as Interim CEO Amid Restructuring - StockTitan

Jan 03, 2025

Dec 30, 2024

Royal Bank of Canada (RY-T) QuotePress Release - The Globe and Mail

Dec 30, 2024

Dec 27, 2024

Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail

Dec 27, 2024

Dec 21, 2024

Trend Tracker for (CYCCP) - Stock Traders Daily

Dec 21, 2024

Dec 20, 2024

Cyclacel stock plunges to 52-week low, hits $0.32 - Investing.com India

Dec 20, 2024

Dec 17, 2024

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by StockNews.com - Defense World

Dec 17, 2024

Dec 17, 2024

Stock Watch: A Biotech Holiday Horror Story - Citeline News & Insights

Dec 17, 2024

Dec 16, 2024

Cyclacel Pharmaceuticals Faces Potential Delisting from Nasdaq Stock Market Due to Minimum Bid Price Noncompliance - Defense World

Dec 16, 2024

Dec 11, 2024

Trading (CYCCP) With Integrated Risk Controls - Stock Traders Daily

Dec 11, 2024

Dec 06, 2024

Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs - The Manila Times

Dec 06, 2024

Dec 05, 2024

Cyclacel Pharmaceuticals Exploring Alternatives, Cuts Costs to Preserve Cash - MarketWatch

Dec 05, 2024

Dec 05, 2024

Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of - EIN News

Dec 05, 2024

Dec 05, 2024

Cyclacel Pharmaceuticals Seeks Urgent Strategic Options Amid Nasdaq Delisting Risk - StockTitan

Dec 05, 2024

Nov 27, 2024

Li Auto Inc ADR (LI-Q) QuotePress Release - The Globe and Mail

Nov 27, 2024

Nov 26, 2024

Cyclacel Pharmaceuticals, Inc. announced that it expects to receive $2.062112 million in funding - Marketscreener.com

Nov 26, 2024

Nov 25, 2024

Cyclacel Pharmaceuticals, Inc. announced that it has received $2.062112 million in funding - Marketscreener.com

Nov 25, 2024

Nov 24, 2024

Cyclacel Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 24, 2024

Nov 22, 2024

Cyclacel stock plunges to 52-week low of $0.32 amid market challenges By Investing.com - Investing.com South Africa

Nov 22, 2024

Nov 21, 2024

Cyclacel stock plunges to 52-week low of $0.32 amid market challenges - Investing.com

Nov 21, 2024

Nov 18, 2024

Cyclacel Pharmaceuticals Reports Q3 2024 Financial Results - TipRanks

Nov 18, 2024

Nov 15, 2024

Cyclacel Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Nov 15, 2024

Nov 15, 2024

Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds - The Manila Times

Nov 15, 2024

Nov 14, 2024

Armistice Capital, LLC Increases Stake in Cyclacel Pharmaceutica - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Cyclacel Pharmaceuticals Raises $2.1M Through Warrant Exercise at $0.415 Per Share | CYCC Stock News - StockTitan

Nov 14, 2024

Nov 14, 2024

Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss - MSN

Nov 14, 2024

Nov 14, 2024

Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds - The Manila Times

Nov 14, 2024

Nov 13, 2024

Cyclacel stock plunges to 52-week low of $0.37 amid market challenges - Investing.com Canada

Nov 13, 2024

Nov 13, 2024

Cyclacel Pharmaceuticals Raises $2.1M Through Warrant Exercise Deal at $0.415 Per Share | CYCC Stock News - StockTitan

Nov 13, 2024

Nov 13, 2024

Cyclacel Pharmaceuticals appoints new auditor By Investing.com - Investing.com Australia

Nov 13, 2024

Nov 13, 2024

Cyclacel Pharmaceuticals appoints new auditor - Investing.com India

Nov 13, 2024

Nov 12, 2024

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update - The Manila Times

Nov 12, 2024

Nov 12, 2024

Cyclacel Faces Delisting Risk Despite 67% Lower Q3 Loss; Cash Concerns Mount | CYCC Stock News - StockTitan

Nov 12, 2024

Nov 09, 2024

(CYCCP) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 09, 2024

Nov 08, 2024

Acute Myeloid Leukemia (AML) Treatment Market in APAC to Grow by USD 305.8 Million from 2024-2028, Driven by High Incidence and AI-Driven Market TransformationTechnavio - The Malaysian Reserve

Nov 08, 2024

Nov 08, 2024

A Data-Based Look At Cyclacel Pharmaceuticals Inc (CYCC) - Stocks Register

Nov 08, 2024

Nov 04, 2024

Cyclacel stock plunges to 52-week low at $0.6 amid market challenges - Investing.com

Nov 04, 2024